| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Life Sciences Funding in Europe (2007) analyses the public, private and
charity funding scenario in European Countries. Analysis of the Framework
Programme 7 and other funding organisations in Europe has been provided. The
countries included in the analysis are the United Kingdom, Germany, France,
Italy and Spain. Challenges faced by the European R&D funding system and the
efforts taken by the countries to tackle these problems have been analysed.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
- Overview of the Life Sciences Funding in Europe
- Executive Summary of the Life Sciences Funding in Europe
2 GLOSSARY
- Glossary of Terms
- Key Acronyms
3 ASSUMPTIONS AND METHODOLOGY
- Research Scope and Methodology
- Research Scope and Segmentation
4 FUNDING IN EUROPE
- Funding Landscape
- European Funding Overview
- European Funding Challenges
- Market Engineering Measurements
- Funding Analysis
5 FUNDING IN THE UNITED KINGDOM
- Funding Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
6 FUNDING IN GERMANY
- Funding Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
7 FUNDING IN FRANCE
- Funding Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
8 FUNDING IN ITALY
- Funding Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
9 FUNDING IN SPAIN
- Funding Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
10 DECISION SUPPORT DATABASE
- Database Tables
- Biotech Companies
- Biotech Private Investment
- Per cent of Government Investment in Biotechnology
- Government Biotech R&D Investment
- Enrollment of Students
|
